PIGA, ISABELLA
 Distribuzione geografica
Continente #
NA - Nord America 4.810
EU - Europa 3.245
AS - Asia 1.419
SA - Sud America 11
AF - Africa 7
OC - Oceania 7
Totale 9.499
Nazione #
US - Stati Uniti d'America 4.743
IT - Italia 1.114
DE - Germania 537
IE - Irlanda 517
CN - Cina 485
SG - Singapore 434
SE - Svezia 364
RU - Federazione Russa 249
HK - Hong Kong 186
VN - Vietnam 137
GB - Regno Unito 126
UA - Ucraina 77
AT - Austria 73
CA - Canada 59
ID - Indonesia 59
FR - Francia 43
DK - Danimarca 36
IN - India 36
FI - Finlandia 25
NL - Olanda 22
JP - Giappone 17
BE - Belgio 14
TR - Turchia 13
TW - Taiwan 13
PL - Polonia 10
BR - Brasile 9
CH - Svizzera 9
AU - Australia 7
CZ - Repubblica Ceca 7
ES - Italia 7
TH - Thailandia 7
IL - Israele 6
MX - Messico 6
IR - Iran 5
MY - Malesia 5
KR - Corea 4
PH - Filippine 4
RO - Romania 4
EG - Egitto 3
LT - Lituania 3
AZ - Azerbaigian 2
HR - Croazia 2
ZA - Sudafrica 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
BD - Bangladesh 1
BG - Bulgaria 1
BT - Bhutan 1
BY - Bielorussia 1
CL - Cile 1
DZ - Algeria 1
EC - Ecuador 1
HU - Ungheria 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MA - Marocco 1
PA - Panama 1
PR - Porto Rico 1
PT - Portogallo 1
TJ - Tagikistan 1
Totale 9.499
Città #
Ann Arbor 1.300
Dublin 506
Chandler 458
Frankfurt am Main 452
Milan 436
Singapore 401
Fairfield 349
Wilmington 307
Ashburn 216
Dearborn 208
Hong Kong 181
Santa Clara 179
New York 171
Woodbridge 157
Seattle 141
Cambridge 138
Princeton 135
Dong Ket 116
Houston 116
Shanghai 106
Nanjing 71
Vienna 68
Jakarta 59
Jacksonville 46
Lawrence 28
Altamura 26
Caronno Pertusella 25
Madison 25
Nanchang 25
Shenyang 25
Beijing 24
Fremont 24
Guangzhou 23
Helsinki 22
Lissone 21
Ottawa 21
Hebei 20
London 20
Toronto 20
San Diego 18
Andover 17
Changsha 17
Cinisello Balsamo 17
Florence 17
Pavia 17
Cagliari 15
Jinan 15
Tianjin 15
Falls Church 14
Romola 13
Zhengzhou 13
Brussels 12
Munich 12
Pune 12
Rome 12
Jiaxing 11
Los Angeles 11
Monza 10
Ningbo 10
Ripalta Cremasca 10
Carate Brianza 9
Chicago 9
Kunming 9
Bergamo 8
Edmonton 8
Gessate 8
Hefei 8
Melzo 8
Norwalk 8
Paris 8
San Giuliano Milanese 8
Sesto San Giovanni 8
Terni 8
Vigevano 8
Washington 8
Kiev 7
Legnano 7
Minamikasugaoka 7
Sacramento 7
Serra 7
Verona 7
Boardman 6
Cilavegna 6
Kelty 6
Padova 6
Piacenza 6
Salt Lake City 6
Taipei 6
Atlanta 5
Bangkok 5
Birmingham 5
Brescia 5
Brno 5
Dallas 5
Hangzhou 5
Lille 5
Lomazzo 5
Scuola 5
Segrate 5
Biandronno 4
Totale 7.220
Nome #
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging 426
Proteomics of liquid biopsies: Depicting RCC infiltration into the renal vein by MS analysis of urine and plasma 361
Feasibility Study for the MALDI-MSI Analysis of Thyroid Fine Needle Aspiration Biopsies: Evaluating the Morphological and Proteomic Stability Over Time 272
Histology-guided proteomic analysis to investigate the molecular profiles of clear cell Renal Cell Carcinoma grades 270
MALDI-MSI Pilot Study Highlights Glomerular Deposits of Macrophage Migration Inhibitory Factor (MIF) as a Possible Indicator of Response to Therapy in Membranous Nephropathy 264
Depth mapping of the urinary N-glycoproteome: Distinct signatures of ccRCC-related progression 262
Antigen Retrieval and Its Effect on the MALDI-MSI of Lipids in Formalin-Fixed Paraffin-Embedded Tissue 261
Matrix-assisted laser desorption/ionisation mass spectrometry imaging in the study of gastric cancer: A mini review 245
The management of haemoglobin interference for the MALDI-MSI proteomics analysis of thyroid fine needle aspiration biopsies 239
TdT expression in germ cell tumours: a possible immunohistochemical cross-reaction and diagnostic pitfall 236
High Spatial Resolution MALDI-MS Imaging in the Study of Membranous Nephropathy 234
Ex vivo thyroid fine needle aspirations as an alternative for MALDI-MSI proteomic investigation: intra-patient comparison 233
Analysis of Hashimoto's thyroiditis on fine needle aspiration samples by MALDI-Imaging 232
MALDI-MSI as a Complementary Diagnostic Tool in Cytopathology: A Pilot Study for the Characterization of Thyroid Nodules 227
Detecting Proteomic Indicators to Distinguish Diabetic Nephropathy from Hypertensive Nephrosclerosis by Integrating Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Imaging with High-Mass Accuracy Mass Spectrometry 216
Molecular trait of follicular-patterned thyroid neoplasms defined by MALDI-imaging 195
Proteomics tools and mass spectometry imaging techiques for the molecular characterization of pancreas 160
Spatial lipidomics of tumour-infiltrating lymphocytes for the typing of colorectal cancer by MALDI mass spectrometry imaging 159
Novel frontiers in diagnostic pathology: MALDI-MSI of thyroid fine needle aspiration biopsies 156
A molecular imaging approach to individuate tumour infiltrating lymphocytes 155
Erratum: Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section (Journal of Proteome Research (2022) 21: 11 (2798−2809) DOI: 10.1021/acs.jproteome.2c00601) 148
Putative salivary biomarkers useful to differentiate patients with fibromyalgia 148
Lipidomic typing of colorectal cancer tissue containing tumour-infiltrating lymphocytes by MALDI mass spectrometry imaging 140
Cytomolecular Classification of Thyroid Nodules Using Fine-Needle Washes Aspiration Biopsies 139
Lights on HBME-1: the elusive biomarker in thyroid cancer pathology 138
Ultra-high resolution MALDI-FTICR-MSI analysis of intact proteins in mouse and human pancreas tissue 136
Update on: proteome analysis in thyroid pathology - part II: overview of technical and clinical enhancement of proteomic investigation of the thyroid lesions 134
Advances in clinical proteomics for analysis of fine needle aspiration biopsies: evaluating proteomics stability in preservative solutions 131
Progress in clinical applications for the proteomics MALDI Imaging analysis of thyroid fine needle aspiration biopsies 125
Glucagon-like peptide 1 protects INS-1E mitochondria against palmitate-mediated beta-cell dysfunction: A proteomic study 123
The evolving landscape of diagnostic pathology: a step towards the integration of MALDI-MSI for the routine diagnosis of thyroid fine needle aspiration biopsies 120
The management of haemoglobin interference for the MALDI-MSI analysis of in-vivo thyroid biopsies 118
Spatially Resolved Molecular Approaches for the Characterisation of Non-Invasive Follicular Tumours with Papillary-like Features (NIFTPs) 112
Determination of total and unbound warfarin and warfarin alcohols in human plasma by high performance liquid chromatography with fluorescence detection 108
Progress in clinical applications for the MALDI-imaging analysis of thyroid fine needle aspiration biopsies: evaluation of proteomic stability in preservative solutions 106
Influence of sampling on the determination of warfarin and warfarin alcohols in oral fluid 106
MALDI-MSI as complementary tool in the characterization of thyroid nodules: novelties and challenges in the evolving landscape of diagnostic pathology 103
C0513: A Non-Invasive Approach for Monitoring Patients Undergoing Anticoagulant Therapy 102
Ultra-high resolution MALDI-FTICR-MSI analysis of intact proteins in mouse and human pancreas tissue 99
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 96
Molecular signatures of medullary thyroid carcinoma by MALDI-MSI 96
MALDI-MS imaging in glomerular kidney diseases: from diagnostics to precision medicine? 94
Recent advances in MALDI mass spectrometry imaging: a cutting edge tool for the diagnosis of thyroid nodules 94
Progress in clinical applications for the MALDI-Imaging analysis of thyroid biopsies: evaluation of proteomic stability in preservative solutions 90
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 87
Towards a standardised protocol for proteomic analysis of thyroid fine-needle-aspiration biopsies by MALDI-MSI: Management of haemoglobin interference 86
High resolution MALDI-FTICR-MSI analysis of intact proteins in mouse pancreas tissue 86
Determination of anticoagulant drugs and their metabolites in oral fluid: strategies for sample collection 83
Determination of Warfarin and Warfarin alcohols in oral fluid and plasma samples for monitoring patients undergoing anticoagulant therapy 83
Unsupervised neural networks as a support tool for pathology diagnosis in MALDI-MSI experiments: A case study on thyroid biopsies 82
Proteomic Fingerprint of Lung Fibrosis Progression and Response to Therapy in Bleomycin-Induced Mouse Model 82
Development of mass spectrometry imaging methods for the analysis of intact proteins in mouse pancreas tissues by MALDI-TOF-MS and MALDI-FTICR-MS 81
Generation of a spectral library for DIA proteomics analysis and application to serum samples using TIMS-TOF MS/MS 79
New frontiers in Pathology: MALDI-MS Imaging for diagnosis of thyroid fine needle aspiration biopsies 79
Glucagon-like peptide-1 protects INS-1E against palmitatemediated β-cell dysfunction: a proteomic study 78
Comparative proteomics of native tuscany cultivars of olea europaea: a preliminary study 78
MALDI-MS Imaging Application in Thyroid FNA: Challenges and Perspectives 78
High resolution MALDI-FTICR-MSI analysis of intact proteins in mouse pancreas tissue 77
Influence of sampling on the measured concentration of Warfarin and Warfarin alcohols in oral fluid 76
New insights in MSI pathology: a molecular snapshot of thyroid cancer 75
Tri-modal MALDI-MS imaging of lipids, N-Glycans, and proteins on a single tissue section 75
Plasma Proteomic Variables Related to COVID-19 Severity: An Untargeted nLC-MS/MS Investigation 73
Determination of anticoagulant drugs and their metabolites in oral fluid and plasma samples by HPLC-Fluorimetry 73
Tri-modal MALDI-MS Imaging: new frontiers in diagnostics 73
Towards lipid MALDI-MS imaging in FFPE tissue: antigen retrieval and its effect on positive ion species 72
Delving deeper into the tissue proteome: improving cell-specificity with high spatial resolution MALDI-MS Imaging 72
Monitoring of warfarin therapy: Preliminary results from a longitudinal pilot study 71
Determination of Warfarin and Warfarin alcohols in saliva and plasma by high performance liquid chromatography with fluorimetric detection 70
Towards the Definition of the Molecular Hallmarks of Idiopathic Membranous Nephropathy in Serum Proteome: A DIA-PASEF Approach 68
New insights in lipids MALDI MS imaging in FFPE tissue: Antigen retrieval and its effect on positive ion species 67
DIA-PASEF mass spectrometry as a tailored proteomic approach to explore Idiopathic Membranous Nephropathy 66
Elaborazione dei dati analitici: valutazione della qualità e costruzione di immagini molecolari 66
Tri-modal MALDI-MS imaging on the same tissue section: deeper molecular insights of disease 58
Spatial Multiomics of Lipids, N-Glycans, and Tryptic Peptides on a Single FFPE Tissue Section 52
Elaborazione dei dati analitici: valutazione della qualità e costruzione di immagini molecolari 51
Serum Mass Spectrometry Proteomics and Protein Set Identification in Response to FOLFOX-4 in Drug-Resistant Ovarian Carcinoma 47
Strumentazione, preparazione del campione, deposito matrice, impostazione e lancio esperimento 44
Paving the path toward multi-omics approaches in the diagnostic challenges faced in thyroid pathology 30
Pathology Laboratory Archives: Conservation Quality of Nucleic Acids and Proteins for NSCLC Molecular Testing 23
Does the urinary proteome reflect ccrcc stage and grade progression? 19
Mapping the distribution of bioactive compounds and aroma/flavour precursors in green coffee beans with an integrated mass spectrometry-based approach 17
Recent Advances in MALDI Mass Spectrometry Imaging: A Cutting-Edge Tool for the Diagnosis of Thyroid Nodules 14
Data analysis optimisation of a DIA-PASEF mass spectrometry approach for the study of idiopathic membranous nephropathy disease 8
Totale 10.108
Categoria #
all - tutte 35.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.702


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.006 0 0 0 0 0 229 261 113 122 119 113 49
2020/20211.895 65 75 198 200 191 218 165 207 118 110 99 249
2021/20221.078 96 98 59 128 60 91 9 60 44 95 115 223
2022/20231.981 219 504 220 162 96 271 21 129 165 34 88 72
2023/20241.632 52 53 78 114 165 447 325 46 130 26 58 138
2024/20251.229 152 277 226 165 278 131 0 0 0 0 0 0
Totale 10.108